-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NoJjcdnkGZPfwir+CiztoTyGqBrW3sIlh/hQpEjeYxzqX2IL3irLaPrj11rnA+kZ xEkLikCel6YfLPxUsW6E4w== 0001193805-11-000294.txt : 20110214 0001193805-11-000294.hdr.sgml : 20110214 20110214163155 ACCESSION NUMBER: 0001193805-11-000294 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101231 FILED AS OF DATE: 20110214 DATE AS OF CHANGE: 20110214 EFFECTIVENESS DATE: 20110214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACCIPITER CAPITAL MANAGEMENT, LLC CENTRAL INDEX KEY: 0001280190 IRS NUMBER: 134220800 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-10741 FILM NUMBER: 11607779 BUSINESS ADDRESS: STREET 1: 399 PARK AVENUE STREET 2: 38TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2127058700 MAIL ADDRESS: STREET 1: 399 PARK AVENUE STREET 2: 38TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: ACCIPITER CAPITAL MANAGEMENT DATE OF NAME CHANGE: 20040213 13F-HR 1 e608015_13fhr-accipiter.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: December 31, 2010 Check here if Amendment /_/; Amendment Number: _______ This Amendment (Check only one): /_/ is a restatement. /_/ adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Accipiter Capital Management, LLC Address: 666 5th Avenue, 35th Floor New York, New York 10103 Form 13F File Number: 28-10741 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Gabe Hoffman Title: Managing Member Phone: 212-705-8700 Signature, Place, and Date of Signing: /s/ Gabe Hoffman, New York, NY, February 14, 2011 Report Type (Check only one): /X/ 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) /_/ 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) /_/ 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 1 --------------- Form 13F Information Table Entry Total: 29 --------------- Form 13F Information Table Value Total: $121,927 --------------- (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. No. Form 13F File Number Name 1 28-11738 Gabe Hoffman ----- ----------------------- ----------------------- FORM 13F INFORMATION TABLE
VOTING AUTHORITY ---------------- TITLE OF VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER NAME OF ISSUER CLASS CUSIP (X$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE -------------- ----- ----- -------- ------- --- ---- ---------- -------- ---- ------ ---- AETNA INC NEW COM COM 00817Y108 10,637 348,646 S/H OTHER 1 - 348,646 - AVANIR PHARM CL A CL A NEW 05348P401 224 55,000 S/H OTHER 1 - 55,000 - BIOMARIN PHARMACEUTICA COM COM 09061G101 6,283 233,305 S/H OTHER 1 - 233,305 - BIOTIME INC COM 09066L105 208 25,000 S/H OTHER 1 - 25,000 - CIGNA CORP COM COM 125509109 5,499 150,000 S/H OTHER 1 - 150,000 - CLEVELAND BIOLABS INC COM 185860103 903 125,000 S/H OTHER 1 - 125,000 - COVENTRY HEALTH CARE INC COM 222862104 5,287 200,283 S/H OTHER 1 - 200,283 - COVIDIEN PLC SHS G2554F105 2,882 63,118 S/H OTHER 1 - 63,118 - CYTORI THERAPEUTICS INC COM 23283K105 260 50,000 S/H OTHER 1 - 50,000 - DYAX CORP COM 26746E103 866 401,000 S/H OTHER 1 - 401,000 - GILEAD SCIENCES INC COM 375558103 9,421 259,973 S/H OTHER 1 - 259,973 - HEALTH MGMT ASSOC INC CL A CL A 421933102 3,589 376,156 S/H OTHER 1 - 376,156 - HEALTHSOUTH CORP COM 421924309 2,662 128,559 S/H OTHER 1 - 128,559 - HI-TECH PHARMACALINC COM 42840B101 4,842 194,059 S/H OTHER 1 - 194,059 - MAKO SURGICAL CORP COM 560879108 4,092 268,865 S/H OTHER 1 - 268,865 - MANNKIND COM 56400P201 81 10,000 S/H OTHER 1 - 10,000 - MELA SCIENCES COM 55277R100 115 34,413 S/H OTHER 1 - 34,413 - NEUROGESX COM 641252101 538 84,631 S/H OTHER 1 - 84,631 - OBAGI MEDICAL PRODUCTS INC COM 67423R108 5,039 436,263 S/H OTHER 1 - 436,263 - ORCHID CELLMARK INC COM 68573C107 7,769 3,923,498 S/H OTHER 1 - 3,923,498 - PURE BIOSCIENCES COM 746218106 11 5,000 S/H OTHER 1 - 5,000 - QUEST DIAGNOSTICS COM 74834L100 2,678 49,628 S/H OTHER 1 - 49,628 - REHABCARE GROUP INC COM 759148109 11,603 489,562 S/H OTHER 1 - 489,562 - RTI BIOLOGICS, INC. COM 74975N105 3,491 1,307,500 S/H OTHER 1 - 1,307,500 - SEQUENOM INC COM 817337405 940 117,000 S/H OTHER 1 - 117,000 - SERVICE CORPORATION INTERNATIONAL COM 817565104 5,915 716,939 S/H OTHER 1 - 716,939 - TEVA PHARM ADR ADR 881624209 5,442 104,400 S/H OTHER 1 - 104,400 - WELLPOINT COM 94973V107 16,192 284,774 S/H OTHER 1 - 284,774 - ZIMMER HLDGS COM 98956P102 4,458 83,049 S/H OTHER 1 - 83,049 -
-----END PRIVACY-ENHANCED MESSAGE-----